September 2nd, 2020Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma clinicaltrials.gov Brief Summary: This phase II trial studies how well belinostat and SGI-110...
Read ArticleAugust 31st, 2020 To view the video on YouTube, click here
Read ArticleAugust 29th, 2020Schwartz Hunts for Predictive Biomarkers in Soft Tissue Sarcoma Gary K. Schwartz, MD, highlights research that is being done with regard to genomic signatures in sarcoma, challenges faced with immunotherapy, and where the field is headed. Gary K....
Read ArticleAugust 16th, 2020Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency Abstract One of the crucial challenges in the clinical management of cancer is resistance to chemotherapeutics. Multidrug resistance (MDR) has been intensively studied,...
Read ArticleAugust 16th, 2020Results of a Prospective Phase 2 Study of Pazopanib in Patients With Surgically Unresectable or Metastatic Chondrosarcoma Warren Chow, MD1; Paul Frankel, PhD2; Chris Ruel, PhD2; Dejka M. Araujo, MD3; Mohammed Milhem, MBBS4; Scott Okuno, MD5; Lee...
Read ArticleAugust 12th, 2020A new article Treating Chondrosarcoma with Urgency and Compassion has just been posted on the Chondrosarcoma Web Site (www.csfshayna.org). You can find the article on the Commentaries page...
Read ArticleAugust 12th, 2020Jeffrey T. Kramer,President: Chondrosarcoma CS Foundation, Inc. Introduction Cancer patients and their families perceive physicians and oncologists as experts in the treatment of cancer. We rely on them for the answers we seek and to...
Read ArticleAugust 10th, 2020Please check out our Web Site www.csfshayna.org to get acquainted with our board of directors and staff for the Chondrosarcoma Foundation.
Read Article